[The Biological Function of SHP2 in Human Disease]

Area of Science:

• Biochemistry
• Molecular Biology
• Genetics

Background:

• Tyrosyl phosphorylation, regulated by protein tyrosine kinases (PTKs) and phosphatases (PTPs), is crucial in physiological and pathological processes.
• The Src homology-2 domain containing phosphatase SHP2 (PTPN11) is implicated in genetic diseases, development, metabolism, neurological, muscle, skeletal disorders, and cancer.
• Mutations in PTPN11 cause genetic syndromes like Noonan Syndrome and LEOPARD syndrome, while somatic mutations are found in various cancers.

Purpose of the Study:

• To summarize the structural basis and recent research on SHP2.
• To elucidate the regulatory mechanisms of SHP2 in human diseases.
• To identify new therapeutic targets for SHP2-related diseases.

Main Methods:

• Literature review of structural biology and disease association studies.
• Analysis of PTPN11 mutations in genetic disorders and cancers.
• Review of SHP2's role in oncogenic signaling pathways.

Main Results:

• SHP2 is involved in diverse cellular functions and disease pathogenesis.
• Germline PTPN11 mutations lead to specific genetic syndromes.
• Somatic PTPN11 mutations are prevalent in hematologic and solid tumors, highlighting its role in cancer progression.
• SHP2's dual role as a potential oncogene or tumor suppressor in cancer requires further investigation.

Conclusions:

• SHP2 is a critical regulator in various human diseases, including genetic disorders and cancers.
• Further elucidation of SHP2's mechanisms will provide insights into disease pathogenesis.
• Targeting SHP2 offers potential therapeutic strategies for a range of human diseases.